Why Ultralife Corporation’s (ULBI) Stock Is Up 17.15%
As of Friday, August 07, Ultralife Corporation’s ULBI share price has surged by 17.15%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Omar Beirat
Rosalio Madrigal
Rosalio Madrigal
Jenna Brashear
| Share Statistics | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $90.8 | $728.7 | 21% |
|
| Shares Out (Mil) | 16.7 | 47.7 | 27% |
|
| Institutional Ownership | 43.7% | 68.1% | 19% |
|
| Float (Mil) | 9.6 | 46.5 | 19% |
|
| Beta | 0.80 | 1.23 | 48% |
|
| Avg Daily Volume (000s) | 37 | 340 | 26% |
|
| Price Change (52-week) |
(20.2%) | 47.1% | 34% |
|
| Growth | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 12.2% | 9.3% | 66% |
|
| Net Income (5yr) | (25.7%) | (2.5%) | 16% |
|
| EPS (5yr) | (25.2%) | 9.2% | 10 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (5.6%) | (14.6%) | 60% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $187 | $482 | 31% |
|
| Net Income (TTM) (Mil) | ($7) | ($2) | 32% |
|
| EPS (TTM) | ($0.393) | ($0.200) | 29% |
|
| Operating Cash Flow (TTM) (Mil) | $5 | ($2) | 36% |
|
| Net Cash Flow (TTM) (Mil) | ($4) | $10 | 34% |
|
| Long-Term Debt (Q1) (Mil) | $45 | $41 | 38% |
|
| Enterprise Value (Q1) (Mil) | $160 | $906 | 24% |
|
| Valuation | ULBI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.69 | 3.11 | 13% |
|
| P/E | na | 33.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 24.4% | 27.6% | 27% |
|
| Net Margin | (3.5%) | 0.5% | 27% |
|
| ROA | (3.0%) | (3.8%) | 32% |
|
| ROE | (4.8%) | 8.2% | 31% |
|
| Liabilities to Assets | 38.7% | 57.4% | 29% |
|
| F-Score | 3 | 4 | 18% |
|
Ultralife Corporation did not pass any screens on 9/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors